These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19536281)

  • 1. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes.
    Radstake TR; van Bon L; Broen J; Hussiani A; Hesselstrand R; Wuttge DM; Deng Y; Simms R; Lubberts E; Lafyatis R
    PLoS One; 2009 Jun; 4(6):e5903. PubMed ID: 19536281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.
    Radstake TR; van Bon L; Broen J; Wenink M; Santegoets K; Deng Y; Hussaini A; Simms R; Cruikshank WW; Lafyatis R
    PLoS One; 2009 Jun; 4(6):e5981. PubMed ID: 19543397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients.
    Krasimirova E; Velikova T; Ivanova-Todorova E; Tumangelova-Yuzeir K; Kalinova D; Boyadzhieva V; Stoilov N; Yoneva T; Rashkov R; Kyurkchiev D
    World J Exp Med; 2017 Aug; 7(3):84-96. PubMed ID: 28890870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.
    Fujii H; Hasegawa M; Takehara K; Mukaida N; Sato S
    Clin Exp Immunol; 2002 Dec; 130(3):548-56. PubMed ID: 12452848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma Peripheral B Lymphocytes Secrete Interleukin-6 and Transforming Growth Factor β and Activate Fibroblasts.
    Dumoitier N; Chaigne B; Régent A; Lofek S; Mhibik M; Dorfmüller P; Terrier B; London J; Bérezné A; Tamas N; Varin-Blank N; Mouthon L
    Arthritis Rheumatol; 2017 May; 69(5):1078-1089. PubMed ID: 27992693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory CD4+ T cells lacking expression of CCR7 promote pro-inflammatory cytokine production in patients with diffuse cutaneous systemic sclerosis.
    Almanzar G; Schmalzing M; Klein M; Hilligardt D; Morris P; Höfner K; Hajj NE; Kneitz H; Wild V; Rosenwald A; Benoit S; Hamm H; Tony HP; Haaf T; Goebeler M; Prelog M
    Eur J Dermatol; 2019 Oct; 29(5):468-476. PubMed ID: 31789272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc).
    Klein M; Schmalzing M; Almanzar G; Benoit S; Hamm H; Tony HP; Goebeler M; Prelog M
    Autoimmunity; 2016 Dec; 49(8):532-546. PubMed ID: 27560622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis.
    Zhou Y; Hou W; Xu K; Han D; Jiang C; Mou K; Li Y; Meng L; Lu S
    Hum Immunol; 2015 Jan; 76(1):22-9. PubMed ID: 25500255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
    Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
    Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness: a cross-sectional study.
    Rodríguez-Reyna TS; Furuzawa-Carballeda J; Cabiedes J; Fajardo-Hermosillo LD; Martínez-Reyes C; Díaz-Zamudio M; Llorente L
    Rheumatol Int; 2012 Sep; 32(9):2653-60. PubMed ID: 21789610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response.
    Andersen GN; Nilsson K; Nagaeva O; Rantapää-Dahlqvist S; Sandström T; Mincheva-Nilsson L
    Scand J Immunol; 2011 Sep; 74(3):272-281. PubMed ID: 21535076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential roles of interleukin-17A in the development of skin fibrosis in mice.
    Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K
    Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.
    Karalilova R; Kazakova M; Sapundzhieva T; Dichev V; Batalov Z; Sarafian V; Batalov A
    Rheumatol Int; 2019 Nov; 39(11):1841-1848. PubMed ID: 31375891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-16 expression is increased in the skin and sera of patients with systemic sclerosis.
    Kawabata K; Makino T; Makino K; Kajihara I; Fukushima S; Ihn H
    Rheumatology (Oxford); 2020 Mar; 59(3):519-523. PubMed ID: 31377804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells drive profibrotic inflammation and aberrant T cell polarization in systemic sclerosis.
    Choreño-Parra JA; Cervantes-Rosete D; Jiménez-Álvarez LA; Ramírez-Martínez G; Márquez-García JE; Cruz-Lagunas A; Magaña-Sánchez AY; Lima G; López-Maldonado H; Gaytán-Guzmán E; Caballero A; Fernández-Plata R; Furuzawa-Carballeda J; Mendoza-Milla C; Navarro-González MDC; Llorente L; Zúñiga J; Rodríguez-Reyna TS
    Rheumatology (Oxford); 2023 Apr; 62(4):1687-1698. PubMed ID: 36063053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.